Various potential therapeutics have been assessed clinically for oral mucositis including recombinant IL-11 [29], granulocyte-macrophage colony-stimulating factor (GM-CSF) [30,31], G-CSF [32] and TGF-β3 [33]. This evidence concerns the gene CSF3 and oral mucositis.